Skip to main content
Top

10-09-2024 | Obstructive Lung Diseases | News

ERS 2024

ABRA study positions benralizumab as new treatment for asthma, COPD exacerbations

Author: Dr. Shreeya Nanda

medwireNews: The combination of benralizumab plus standard corticosteroids is better than corticosteroids alone for the treatment of acute eosinophilic exacerbations of asthma and chronic obstructive pulmonary disease (COPD), indicate data presented at the ERS Congress 2024.

Related topics

SPONSORED

Targeting COPD with type 2 inflammation: emerging biologic landscape

  • Live
  • Webinar | 03-12-2024 | 19:00 (CET)

LIVE: Tuesday, 3 December 2024, 19:00-20:30 (CET)

Join us for an insightful session tailored for pulmonologists and healthcare professionals eager to enhance their understanding of COPD and the latest advances in biologic therapies. 

Sponsored by:
  • Sanofi
Developed by: Springer Healthcare
Reserve your place

A quick guide to ECGs

Improve your ECG interpretation skills with this comprehensive, rapid, interactive course. Expert advice provides detailed feedback as you work through 50 ECGs covering the most common cardiac presentations to ensure your practice stays up to date. 

PD Dr. Carsten W. Israel
Developed by: Springer Medizin
Start the cases